RHÖN-KLINIKUM AG  / Key word(s): Disposal/Miscellaneous

20.02.2014 13:18

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



The German Cartel Office today granted merger control clearance for the
transaction with Frese-nius/HELIOS without restrictions and conditions. The
merger control clearance comprises 40 clinics, medical centers and related
companies and thus the entire sold portfolio except for the clinics in
Cuxhaven, Waltershausen-Friedrichroda und Boizenburg and two management
companies for medical centers. The excepted companies were, in coordination
with the Cartel Office, removed from the sold portfolio already prior to
the merger control clearance.

The cleared transaction will for the most part be closed until end of
February 2014 by payment of the purchase price and transfer of the shares.
The transfer of two clinics and three service companies is still subject to
third party consent and will, subject to the consent being granted, be
closed at a later point.

The purchase price for the transaction cleared by the German Cartel Office
amounts to about EUR 3 billion (enterprise value) before adjustments
resulting from specific cash and debt items. The company still plans to
reflect the sale in large parts in the financial statements of the business
year 2013. This would set the ground for a binding shareholders' resolution
on the allocation of funds at the general shareholders' meeting in June
2014. On this basis, a large part of the up to EUR 1.9 billion earmarked to
that can be proposed for distribution to the shareholders - preferably by
means of a share repurchase - already in 2014.


***************************************************************************
RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. Its
corporate objective is high-quality medical care for everyone. Currently,
our Group counts 54 hospitals at 43 sites throughout Germany. We employ
around 43,000 people. In financial year 2012, nearly 2.5 million patients
were treated in the Group's facilities.
Further information is available at: www.rhoen-klinikum-ag.com

Contact:
Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1318
Telefax: +49 (0) 9771 99-1736

Achim Struchholz
Corporate Communications
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1327
Telefax: +49 (0) 9771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com 


20.02.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Phone:        +49 (0)9771 - 65-0
Fax:          +49 (0)9771 - 97 467
E-mail:       rka@rhoen-klinikum-ag.com
Internet:     www.rhoen-klinikum-ag.com
ISIN:         DE0007042301
WKN:          704230
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), München;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
 
End of Announcement                             DGAP News-Service